Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy

Takashi Tsuboi, Hirohisa Watanabe, Kouhei Funasaka, Mikiko Takebayashi, Kazushi Miyata, Masahisa Katsuno

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

A 58-year-old man with Parkinson's disease experienced peritonitis after percutaneous endoscopic gastrojejunostomy (PEG-J) for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy. Although gastropexy reduces complications including peritonitis, clinicians should consider structural characteristics of PEG-J devices and patients’ anatomical differences. We recommend that suture threads are removed 2–4 weeks after PEG-J and that the PEG-J tube length outside the body is routinely recorded to assess tube dislocation.

Original languageEnglish
Pages (from-to)64-66
Number of pages3
JournalNeurology and Clinical Neuroscience
Volume6
Issue number2
DOIs
Publication statusPublished - 03-2018
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa–carbidopa intestinal gel treatment despite concomitant use of gastropexy'. Together they form a unique fingerprint.

Cite this